ImmunityBio, Inc.IBRXNASDAQ

Revenue (LTM)

$113M

+668.3% YoY

Net Income (LTM)

$-351M

+15.0% YoY

Free Cash Flow

$-309M

Revenue CAGR (5Y)

+231.9%

—Marginsstable

FCF($0.3B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	0↓74.3%	1↑159.2%	15↑2270.6%	113↑668.3%
Gross Profit	1	0↓74.3%	1↑159.2%	15↑2270.6%	113↑663.2%
Operating Income	-330	-351↓6.4%	-362↓3.1%	-344↑5.0%	-256↑25.6%
Net Income	-347	-417↓20.1%	-583↓40.0%	-414↑29.1%	-351↑15.0%
EBITDA	-321	-352↓9.7%	-479↓36.0%	-264↑44.8%	-224↑15.5%
EPS Diluted	-0.89	-1.04↓16.9%	-1.15↓10.6%	-0.62↑46.1%	-0.38↑38.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	181	105↓42.2%	265↑153.7%	143↓46.0%	88↓38.4%
Total Current Assets	334	141↓58.0%	294↑109.2%	185↓37.2%	315↑70.6%
Total Assets	469	362↓22.7%	504↑39.2%	383↓24.1%	502↑31.1%
Total Current Liabilities	369	501↑35.7%	58↓88.4%	55↓5.7%	62↑12.4%
Total Liabilities	713	812↑13.9%	1,090↑34.3%	871↓20.1%	1,001↑15.0%
Total Equity	-242	-447↓84.7%	-587↓31.2%	-489↑16.7%	-500↓2.1%
Total Debt	646	724↑12.1%	727↑0.4%	504↓30.6%	878↑74.2%
Net Debt	465	619↑33.3%	461↓25.5%	361↓21.8%	790↑118.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-274	-338↓23.0%	-367↓8.7%	-391↓6.7%	-305↑22.1%
Capital Expenditure	-34	-78↓132.9%	-31↑60.9%	-7↑77.5%	-4↑44.2%
Free Cash Flow	-308	-416↓35.0%	-397↑4.4%	-398↓0.2%	-309↑22.4%
Stock-Based Comp	57	40↓29.7%	49↑22.4%	34↓30.0%	0
Net Change in Cash	146	-76↓152.2%	161↑310.7%	-122↓175.8%	-54↑55.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance